Annual SG&A
$12.72 M
-$2.54 M-16.67%
31 December 2023
Summary:
Innate Pharma SA annual selling, general & administrative expenses is currently $12.72 million, with the most recent change of -$2.54 million (-16.67%) on 31 December 2023. During the last 3 years, it has fallen by -$6.20 million (-32.78%). IPHA annual SG&A is now -66.66% below its all-time high of $38.15 million, reached on 31 December 2017.IPHA Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
N/A
30 June 2024
Summary:
Innate Pharma SA quarterly selling, general & administrative expenses is not available.IPHA Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$760.06 M
-$30.56 M-4.19%
30 June 2024
Summary:
Innate Pharma SA TTM selling, general & administrative expenses is currently -$760.06 million, with the most recent change of -$30.56 million (-4.19%) on 30 June 2024. IPHA TTM SG&A is now -740.69% below its all-time high of $204.41 million, reached on 01 April 2019.IPHA TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPHA Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -32.8% | - | - |
| 5 y5 years | -23.1% | - | -474.6% |
IPHA Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -32.8% | at low | -29.7% | at low | ||
| 5 y | 5 years | -32.8% | at low | -110.5% | at low | ||
| alltime | all time | -66.7% | +99.4% | -740.7% | at low |
Innate Pharma SA Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $12.72 M(-16.7%) | - | - |
| Dec 2022 | $15.26 M(-19.3%) | - | - |
| Dec 2021 | $18.92 M(+30.5%) | - | - |
| Apr 2021 | - | $49.28 M(+3.8%) | $193.79 M(-1.6%) |
| Jan 2021 | - | $47.50 M(+2.2%) | $196.85 M(-0.7%) |
| Dec 2020 | $14.49 M(-12.4%) | - | - |
| Oct 2020 | - | $46.46 M(-8.1%) | $198.23 M(-2.3%) |
| July 2020 | - | $50.55 M(-3.4%) | $202.94 M(-0.7%) |
| Apr 2020 | - | $52.34 M(+7.1%) | $204.39 M(+0.7%) |
| Jan 2020 | - | $48.88 M(-4.5%) | $202.87 M(-0.3%) |
| Dec 2019 | $16.55 M | - | - |
| Oct 2019 | - | $51.17 M(-1.6%) | $203.53 M(-0.1%) |
| July 2019 | - | $52.00 M(+2.3%) | $203.72 M(-0.3%) |
| Apr 2019 | - | $50.82 M(+2.6%) | $204.41 M(+33.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2019 | - | $49.53 M(-3.6%) | $153.59 M(+47.6%) |
| Dec 2018 | $21.52 M(-43.6%) | - | - |
| Oct 2018 | - | $51.37 M(-2.5%) | $104.06 M(+97.5%) |
| July 2018 | - | $52.69 M | $52.69 M |
| Dec 2017 | $38.15 M(+269.5%) | - | - |
| Dec 2016 | $10.32 M(+58.3%) | - | - |
| Dec 2015 | $6.52 M(+2.3%) | - | - |
| Dec 2014 | $6.38 M(-55.0%) | - | - |
| Dec 2013 | $14.17 M(+13.2%) | - | - |
| Dec 2012 | $12.51 M(-11.4%) | - | - |
| Dec 2011 | $14.13 M(+51.0%) | - | - |
| Dec 2010 | $9.35 M(-33.3%) | - | - |
| Dec 2009 | $14.03 M(-20.0%) | - | - |
| Dec 2008 | $17.54 M | - | - |
FAQ
- What is Innate Pharma SA annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Innate Pharma SA?
- What is the all time high quarterly SG&A for Innate Pharma SA?
- What is Innate Pharma SA TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Innate Pharma SA?
What is Innate Pharma SA annual selling, general & administrative expenses?
The current annual SG&A of IPHA is $12.72 M
What is the all time high annual SG&A for Innate Pharma SA?
Innate Pharma SA all-time high annual selling, general & administrative expenses is $38.15 M
What is the all time high quarterly SG&A for Innate Pharma SA?
Innate Pharma SA all-time high quarterly selling, general & administrative expenses is $52.69 M
What is Innate Pharma SA TTM selling, general & administrative expenses?
The current TTM SG&A of IPHA is -$760.06 M
What is the all time high TTM SG&A for Innate Pharma SA?
Innate Pharma SA all-time high TTM selling, general & administrative expenses is $204.41 M